FTM
FULC icon

First Turn Management’s Fulcrum Therapeutics FULC Stock Holding History

First Turn Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3M Buy
2,256,109
+363,426
+19% +$3.37M 1.93% 25
2025
Q4 		$21.4M Buy
+1,892,683
New +$19.3M 2.45% 20

Other funds holding FULC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

First Turn Management's FULC Position: Q1 2026 in Review

First Turn Management increased its Fulcrum Therapeutics (FULC) stake by 19% in Q1 2026, buying an estimated $3.37M and bringing the position to 2,256,109 shares worth $17.3M. The position accounts for 1.93% of the portfolio, ranked #25.

First Turn Management first reported a position in FULC in Q4 2025 and has held it in 2 quarters since. The position peaked at $21.4M in Q4 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

  • First Turn Management held 2,256,109 shares of Fulcrum Therapeutics worth $17.3M as of Q1 2026.
  • First Turn Management bought 363,426 Fulcrum Therapeutics shares in Q1 2026, an estimated $3.37M.
  • Fulcrum Therapeutics made up 1.93% of First Turn Management's portfolio in Q1 2026, its #25 holding.
  • First Turn Management first reported a position in Fulcrum Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • First Turn Management's Fulcrum Therapeutics position peaked at $21.4M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on First Turn Management's 13F filing for Q1 2026, filed 15 May 2026.